APA (7th ed.) Citation

Martina, V., Karmen, S., Stasa, J., Eva, C., Lina, V. A., & Jasna, B. (2021). Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience. Sciendo.

Chicago Style (17th ed.) Citation

Martina, Vrankar, Stanic Karmen, Jelercic Stasa, Ciric Eva, Vodusek Ana Lina, and But-Hadzic Jasna. Clinical Outcomes in Stage III Non-small Cell Lung Cancer Patients Treated with Durvalumab After Sequential or Concurrent Platinum-based Chemoradiotherapy – Single Institute Experience. Sciendo, 2021.

MLA (8th ed.) Citation

Martina, Vrankar, et al. Clinical Outcomes in Stage III Non-small Cell Lung Cancer Patients Treated with Durvalumab After Sequential or Concurrent Platinum-based Chemoradiotherapy – Single Institute Experience. Sciendo, 2021.